These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 8590577)

  • 1. Bioavailability comparison between albendazole and albendazole sulphoxide in rats and man.
    Dominguez L; Fagiolino P; Gordon S; Manta E
    Farmaco; 1995 Oct; 50(10):697-702. PubMed ID: 8590577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipidic matrix of albendazole sulphoxide: is it an alternative for systemic infections?
    Domínguez L; Savio E; Saldaña J; Malanga A; Quevedo D; Camarote C; Ochoa A; Fagiolino P
    Boll Chim Farm; 1998 Nov; 137(10):383-6. PubMed ID: 9880943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma disposition and faecal excretion of oxfendazole, fenbendazole and albendazole following oral administration to donkeys.
    Gokbulut C; Akar F; McKellar QA
    Vet J; 2006 Jul; 172(1):166-72. PubMed ID: 16772142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-dependent activity of albendazole against benzimidazole-resistant nematodes in sheep: relationship between pharmacokinetics and efficacy.
    Moreno L; Echevarria F; Muñoz F; Alvarez L; Sanchez Bruni S; Lanusse C
    Exp Parasitol; 2004; 106(3-4):150-7. PubMed ID: 15172222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of albendazole sulfoxide enantiomers administered in racemic form and separately in rats.
    Capece BP; Castells G; Godoy C; Arboix M; Cristòfol C
    Vet J; 2008 Aug; 177(2):297-9. PubMed ID: 17566773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of dose increase or cimetidine co-administration on albendazole bioavailability.
    Schipper HG; Koopmans RP; Nagy J; Butter JJ; Kager PA; Van Boxtel CJ
    Am J Trop Med Hyg; 2000; 63(5-6):270-3. PubMed ID: 11421376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of solubilization on the oral bioavailability of three benzimidazole carbamate drugs.
    Daniel-Mwambete K; Torrado S; Cuesta-Bandera C; Ponce-Gordo F; Torrado JJ
    Int J Pharm; 2004 Mar; 272(1-2):29-36. PubMed ID: 15019066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time dependent pharmacokinetics of albendazole in human.
    Mirfazaelian A; Rouini MR; Dadashzadeh S
    Biopharm Drug Dispos; 2003 Jul; 24(5):199-204. PubMed ID: 12784319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose dependent pharmacokinetics of albendazole in human.
    Mirfazaelian A; Rouini MR; Dadashzadeh S
    Biopharm Drug Dispos; 2002 Dec; 23(9):379-83. PubMed ID: 12469331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipidic matrix of albendazole: an alternative for systemic infections.
    Savio E; Domínguez L; Malanga A; Quevedo D; Saldaña J; Camarote C; Ochoa A; Fagiolino P
    Boll Chim Farm; 1998 Oct; 137(9):345-9. PubMed ID: 9859596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of repeated doses of albendazole on enantiomerism of its sulfoxide metabolite in goats.
    Benoit E; Besse S; Delatour P
    Am J Vet Res; 1992 Sep; 53(9):1663-5. PubMed ID: 1416373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of amphiphilic surfactant agents on the gastrointestinal absorption of albendazole in cattle.
    Virkel G; Imperiale F; Lifschitz A; Pis A; Alvarez A; Merino G; Prieto J; Lanusse C
    Biopharm Drug Dispos; 2003 Apr; 24(3):95-103. PubMed ID: 12673667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methimazole-mediated enhancement of albendazole oral bioavailability and anthelmintic effects against parenteral stages of Trichinella spiralis in mice: the influence of the dose-regime.
    López-García ML; Torrado S; Torrado S; Martínez AR; Bolás F
    Vet Parasitol; 1998 Feb; 75(2-3):209-19. PubMed ID: 9637222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving bioavailability and anthelmintic activity of albendazole by preparing albendazole-cyclodextrin complexes.
    García-Rodriguez JJ; Torrado J; Bolás F
    Parasite; 2001 Jun; 8(2 Suppl):S188-90. PubMed ID: 11484352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the interaction between ivermectin and albendazole following their combined use in lambs.
    Alvarez L; Lifschitz A; Entrocasso C; Manazza J; Mottier L; Borda B; Virkel G; Lanusse C
    J Vet Pharmacol Ther; 2008 Jun; 31(3):230-9. PubMed ID: 18471144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inclusion complex and nanoclusters of cyclodextrin to increase the solubility and efficacy of albendazole.
    Pacheco PA; Rodrigues LNC; Ferreira JFS; Gomes ACP; Veríssimo CJ; Louvandini H; Costa RLD; Katiki LM
    Parasitol Res; 2018 Mar; 117(3):705-712. PubMed ID: 29327323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver microsomal biotransformation of albendazole in deer, cattle, sheep and pig and some related wild breeds.
    Velík J; Baliharová V; Skálová L; Szotáková B; Wsól V; Lamka J
    J Vet Pharmacol Ther; 2005 Aug; 28(4):377-84. PubMed ID: 16050818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I biotransformation of albendazole in lancet fluke (Dicrocoelium dendriticum).
    Cvilink V; Szotáková B; Krízová V; Lamka J; Skálová L
    Res Vet Sci; 2009 Feb; 86(1):49-55. PubMed ID: 18565554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetics of albendazole in patients with neurocysticercosis.
    Castro N; Márquez-Caraveo C; Brundage RC; González-Esquivel D; Suárez AM; Góngora F; Jara A; Urizar J; Lanao JM; Jung H
    Int J Clin Pharmacol Ther; 2009 Nov; 47(11):679-85. PubMed ID: 19840532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of surfactants on oral bioavailability of albendazole based on the formation of the sulphoxide metabolites in rats.
    Redondo PA; Alvarez AI; García JL; Villaverde C; Prieto JG
    Biopharm Drug Dispos; 1998 Jan; 19(1):65-70. PubMed ID: 9510986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.